Skip to main content
Fig. 4 | Virology Journal

Fig. 4

From: Nucleos(t)ide analogs continuation is not associated with a lower risk of HBsAg seroreversion following PEG-IFN-induced HBsAg loss

Fig. 4

Timeline of HBsAg seroreversion, virological relapse, and re-HBsAg seroclearance in patients with HBsAg seroreversion. Each line represents a patient with HBsAg seroreversion. The length of the bar indicates the follow-up duration in weeks. The colors of the line represent the different antiviral treatments. The symbols represent HBsAg seroreversion, virological relapse, and re-HBsAg seroclearance. HBsAg, hepatitis B surface antigen

Back to article page

Virology Journal

ISSN: 1743-422X